| scholarly article | Q13442814 |
| P356 | DOI | 10.1034/J.1399-0012.2003.00066.X |
| P698 | PubMed publication ID | 14703925 |
| P2093 | author name string | George W Burke | |
| Joshua Miller | |||
| David Roth | |||
| Gaetano Ciancio | |||
| Warren Kupin | |||
| Adela Mattiazzi | |||
| P2860 | cites work | A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group | Q41439111 |
| The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants | Q43551302 | ||
| Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial | Q43552822 | ||
| Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients | Q43966588 | ||
| A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation | Q46752311 | ||
| Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation. | Q50984356 | ||
| A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1 | Q57704207 | ||
| Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients | Q67249842 | ||
| Analysis of Infectious Complications Occurring After Solid-Organ Transplantation | Q67741230 | ||
| A randomized prospective comparison of MALG with OKT3 for rescue therapy of acute myocardial rejection | Q67897351 | ||
| Successful retreatment of allograft rejection with OKT3 | Q69292684 | ||
| Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection | Q70407027 | ||
| Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center | Q72835772 | ||
| Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis | Q72948444 | ||
| Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation | Q73285880 | ||
| Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis | Q73848274 | ||
| Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection | Q73928369 | ||
| Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings | Q73949421 | ||
| Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group | Q74038855 | ||
| Long-term renal retransplantation and graft survival rates at our center | Q74571148 | ||
| Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group | Q77916212 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 428-432 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Clinical Transplantation | Q15754920 |
| P1476 | title | The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants | |
| P478 | volume | 17 |
| Q43071206 | Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation |
| Q83725168 | Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation |
| Q35779394 | Daclizumab induction in solid organ transplantation |
| Q37025883 | Induction therapy in renal transplantation : an overview of current developments |
| Q27664283 | Structural basis of immunosuppression by the therapeutic antibody daclizumab |
| Q37273477 | Two doses of humanized anti-CD25 antibody in renal transplantation: a preliminary comparative study |
| Q38246132 | Type 2 diabetes: is pancreas transplantation an option? |
Search more.